186 related articles for article (PubMed ID: 22416189)
1. Interleukin-8, a promising predictor for prognosis of pancreatic cancer.
Chen Y; Shi M; Yu GZ; Qin XR; Jin G; Chen P; Zhu MH
World J Gastroenterol; 2012 Mar; 18(10):1123-9. PubMed ID: 22416189
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer.
Feng L; Qi Q; Wang P; Chen H; Chen Z; Meng Z; Liu L
J Int Med Res; 2018 Dec; 46(12):5228-5236. PubMed ID: 30304975
[TBL] [Abstract][Full Text] [Related]
3. IL-8-Positive Tumor-Infiltrating Inflammatory Cells Are a Novel Prognostic Marker in Pancreatic Ductal Adenocarcinoma Patients.
Fang Y; Saiyin H; Zhao X; Wu Y; Han X; Lou W
Pancreas; 2016; 45(5):671-8. PubMed ID: 26495785
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
[TBL] [Abstract][Full Text] [Related]
5. Effects of Qingyi Huaji decoction on serum levels of interleukin-6, interleukin-8 and tumor necrosis factor-alpha in nude mice bearing pancreatic tumors.
Ouyang HQ; Liu LM; Chen Z; Luo JM; Yu EX
Zhong Xi Yi Jie He Xue Bao; 2010 Jul; 8(7):655-61. PubMed ID: 20619142
[TBL] [Abstract][Full Text] [Related]
6. The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases.
Chen L; Fan J; Chen H; Meng Z; Chen Z; Wang P; Liu L
Sci Rep; 2014 Aug; 4():5911. PubMed ID: 25081383
[TBL] [Abstract][Full Text] [Related]
7. Development of serum parameters panels for the early detection of pancreatic cancer.
Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
[TBL] [Abstract][Full Text] [Related]
8. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
9. Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells.
Kuwada Y; Sasaki T; Morinaka K; Kitadai Y; Mukaida N; Chayama K
Int J Oncol; 2003 Apr; 22(4):765-71. PubMed ID: 12632066
[TBL] [Abstract][Full Text] [Related]
10. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.
Ebrahimi B; Tucker SL; Li D; Abbruzzese JL; Kurzrock R
Cancer; 2004 Dec; 101(12):2727-36. PubMed ID: 15526319
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum p53 antigen in patients with pancreatic carcinomas.
Suwa H; Ohshio G; Okada N; Wang Z; Fukumoto M; Imamura T; Imamura M
Gut; 1997 May; 40(5):647-53. PubMed ID: 9203945
[TBL] [Abstract][Full Text] [Related]
13. Serum fatty acid synthase as a marker of pancreatic neoplasia.
Walter K; Hong SM; Nyhan S; Canto M; Fedarko N; Klein A; Griffith M; Omura N; Medghalchi S; Kuhajda F; Goggins M
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2380-5. PubMed ID: 19723916
[TBL] [Abstract][Full Text] [Related]
14. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.
Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR
Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Xiaotan Sanjie Decoction on expressions of interleukin-8 and its receptors in gastric tumor xenografts and gastric tissue adjacent to the tumor in mice].
Ju DW; Wei PK; Lin HM; Sun DZ; Yu S; Xiu LJ
Zhong Xi Yi Jie He Xue Bao; 2010 Jan; 8(1):74-9. PubMed ID: 20082763
[TBL] [Abstract][Full Text] [Related]
16. Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer.
Ren C; Chen Y; Han C; Fu D; Chen H
Tumour Biol; 2014 Nov; 35(11):11467-72. PubMed ID: 25123265
[TBL] [Abstract][Full Text] [Related]
17. Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer.
He XY; Liu BY; Yao WY; Zhao XJ; Zheng Z; Li JF; Yu BQ; Yuan YZ
J Dig Dis; 2011 Apr; 12(2):131-7. PubMed ID: 21401899
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Lehtinen L; Carpen O; Andersson LC; Seppänen H; Haglund C
Tumour Biol; 2018 Mar; 40(3):1010428318761494. PubMed ID: 29542402
[TBL] [Abstract][Full Text] [Related]
19. IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients.
Ma Y; Ren Y; Dai ZJ; Wu CJ; Ji YH; Xu J
Adv Clin Exp Med; 2017; 26(3):421-426. PubMed ID: 28791816
[TBL] [Abstract][Full Text] [Related]
20. Value of CXCL8-CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study.
Wang RX; Ji P; Gong Y; Shao ZM; Chen S
Breast Cancer Res Treat; 2020 Jun; 181(3):561-570. PubMed ID: 32361849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
